Top

Cannvas.Me Cannabis Education Platform Goes Live on October 4, 2018

Cannvas.Me Cannabis Education Platform Goes Live on October 4, 2018

Global Data-Driven Cannabis Education Platform Features Unbiased Physician-Backed Content 

TORONTO, Sept. 26, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce that Cannvas.Me, its first cannabis-centric service offering to the public, will go live on October 4, 2018. Cannvas.Me is a scalable and comprehensive solution for the global cannabis community offering interactive tools and physician-backed content to all audiences wishing to learn about health care through cannabis.

“With the legalization of cannabis in Canada quickly approaching, Cannvas.Me fills the information void with a wide range of credible information on the potential benefits of cannabis,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. “Our solution is to have information available to customers where and when they need it. It could be on a tablet in a medical clinic or doctor’s office, at home on a desktop, or anywhere on a mobile device. Cannvas.Me is there to provide valuable physician-backed information and content, and because we are not affiliated with any of the large cannabis producers we can assure customers our information is truly unbiased.”

Cannvas has been systematic in its approach to the development of the innovative platform, ensuring a best-in-class experience for all users. The free platform utilizes machine-learning algorithms and artificial intelligence (AI) to contextualize and adapt to its users. Content will be served in a geographic and personal manner relevant to the customer.  The contextual AI-supported service also ensures each customer’s journey is built upon their last interaction, giving individuals a uniquely progressive experience.

Cannvas.Me features an innovative set of tools making cannabis education approachable and accessible to a global audience, including:

  • educational learning modules created by medical practitioners and certified educators as part of its Cannvas Academy;
  • an interactive Cannvas Strain Matcher teaching users which strains best alleviate specific ailments;
  • curated recipes and culinary cannabis training with Cannvas Culinary;
  • and more.

The physician-backed information presented on the site is vetted through a series of systems and reviews to ensure the most accurate and up-to-date information is available.  Cannvas has formed three advisory boards and panels with seasoned medical and educational professionals who are at the forefront of their respective fields:

  • Health and Innovation Advisory Board
  • Medical Advisory Board
  • Education Advisory Panel

The members of the advisory boards work with the senior executive team to create original content for the platform offering users relevant and credible information in a rich and contextual environment.

“A lot of hard work and effort has gone into the first phase of Cannvas.Me and we welcome everyone to come and explore the platform on October 4, 2018,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “We are working with a growing list of partners to expand our business and welcome new customers from all walks of life. Additional features will be added in weekly updates of Cannvas.Me and while we are focused on Canada for our launch, we look forward to expanding our offering to global markets in the future.”

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

SOURCE Cannvas MedTech Inc.

For further information: www.cannvasmedtech.com; Media Inquiries: media@cannvasmedtech.com; Investor Relations, ir@cannvasmedtech.com, 1-800-489-0116

X